Cronos Group Inc.
TSX:CRON.TODrug Manufacturers - Specialty & Generic
Healthcare
$4.57 -0.27%
-$0.01 today
- Market cap
- $1.67B
- Beta
- 1.25
- P/E (TTM)
- -488.1
- EPS (TTM)
- -$0.01
52W Low $2.54High $4.66
Volume 0.15M
Average 0.19M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
$26.32M
FY 2025 · Annual
+39.7% YoYInvesting Cash Flow
-$77.90M
FY 2025 · Annual
Financing Cash Flow
-$20.25M
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (397.2M) | (168.73M) | (74.55M) | 40.02M | (9.61M) |
| Depreciation & Amortization | 15.4M | 13.12M | 8.11M | 9.34M | 14.48M |
| Deferred Income Tax | 222.22M | 0 | 43.32M | 0 | 0 |
| Stock-Based Compensation | 10.15M | 15.12M | 8.77M | 8.7M | 0 |
| Change in Working Capital | (2.01M) | 20.66M | (26.47M) | (311K) | (35.02M) |
| Accounts Receivables | (13.16M) | (2.71M) | 9.21M | (2.51M) | (26.2M) |
| Inventory | 11.57M | (7.22M) | 7.4M | 7.42M | (10.58M) |
| Accounts Payables | (2.37M) | (863K) | (773K) | (7.45M) | 1.13M |
| Other Working Capital | 1.97M | 31.45M | (42.3M) | 2.24M | 636.96K |
| Other Non-Cash Items | (2.18M) | 30.89M | (2.01M) | (38.9M) | 56.47M |
| Operating Cash Flow | (153.62M) | (88.95M) | (42.84M) | 18.84M | 26.32M |
| Capital Expenditures | (12.26M) | (5.03M) | (3.42M) | (13.15M) | (26.17M) |
| Acquisitions (Net) | (1.12M) | 0 | 724K | 5.99M | 2.9M |
| Purchases of Investments | (230M) | (271.38M) | (608.25M) | 0 | (59.44M) |
| Sales of Investments | 215.3M | 268.87M | 532.84M | 185.82M | 5.15M |
| Other Investing Activities | (819K) | 5.7M | 18.61M | (4.25M) | 0 |
| Investing Cash Flow | (28.9M) | (1.84M) | (59.5M) | 175.15M | (77.9M) |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 15.73K | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | (2.85M) | (1.03M) | 0 | (9.91M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (13.46M) | (42.36K) | (2.47K) | (1.23M) | (10.34M) |
| Financing Cash Flow | (13.44M) | (2.9M) | (1.03M) | (1.23M) | (20.25M) |
| Effect of Forex Changes | 4.91M | (28.64M) | 8.01M | (3.25M) | (37.24M) |
| Net Change in Cash | (191.05M) | (122.33M) | (95.35M) | 189.51M | (109.07M) |
| Free Cash Flow | (165.88M) | (93.98M) | (46.26M) | 5.69M | 151.61K |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$9.6M
+ D&A$14.5M
+ Stock-Based Comp$0
+ Deferred Tax$0
- Working Capital-$35.0M
+ Other Non-Cash$56.5M
= Operating Cash Flow$26.3M
- Capex-$26.2M
= Free Cash Flow$151.6K
Analysis
FY2025 free cash flow is $151.6K. FCF conversion is -1.6% of net income. Operating cash flow was $26.3M, with capex of -$26.2M. The largest bridge item is Other Non-Cash at $56.5M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
No filings found.
Does CRON.TO generate free cash flow?
Cronos Group Inc. (CRON.TO) generated $151,611.00 of free cash flow in fiscal 2025.
How much operating cash flow does CRON.TO produce?
Operating cash flow was $26.32M, before capital expenditures of $26.17M.
Continue the stock analysis
Jump to another research area for this company.